Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3. (Q33947270)

30 July 2017

Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3. (English)

1 reference

30 July 2017

1 reference

S Réhault

1

1 reference

30 July 2017

P Monget

2

1 reference

30 July 2017

S Mazerbourg

3

1 reference

30 July 2017

R Tremblay

4

1 reference

30 July 2017

N Gutman

5

1 reference

30 July 2017

F Gauthier

6

1 reference

30 July 2017

T Moreau

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

30 July 2017

1 reference

30 July 2017

268

1 reference

30 July 2017

10

1 reference

30 July 2017

2960-2968

1 reference

Identification of insulin-like growth factor-binding protein-2 (IGF-BP-2) and a low molecular weight IGF-BP in human seminal plasma

30 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Insulinlike growth factor-binding protein proteolysis an emerging paradigm in insulinlike growth factor physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

The new human kallikrein gene family: implications in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Purification of enzymatically active kallikrein hK2 from human seminal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

The cleavage site specificity of human prostate specific antigen for insulin-like growth factor binding protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Role of insulin-like growth factor binding proteins in the control of IGF actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Mechanism by which heparin proteoglycan modulates mast cell chymase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Proteoglycans: master regulators of molecular encounter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Structure-function analysis of the human insulin-like growth factor binding protein-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Endothelium-derived factors as paracrine mediators of prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

The Insulin-like Growth Factor (IGF) Binding Site of Bovine Insulin-like Growth Factor Binding Protein-2 (bIGFBP-2) Probed by Iodination

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Localization of an Insulin-like Growth Factor (IGF) Binding Site of Bovine IGF Binding Protein-2 Using Disulfide Mapping and Deletion Mutation Analysis of the C-terminal Domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Simple purification procedure for human prostatic kallikrein hK2 in its active form

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Active-site titration of peptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02185.X

10.1046/J.1432-1327.2001.02185.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference